Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07348640 · ClinicalTrials.gov registry record · Phase 3
Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease
A Phase 3 study, sponsored by Guerbet.
- Not yet
- Registry status
- Phase 3
- Development phase
- 315
- Enrollment target
NCT07348640 is a Phase 3 study that has not yet begun recruiting, run by Guerbet. The registered enrollment target is 315 participants.
The verdict
NCT07348640, a Phase 3 study, has not yet begun recruiting, sponsored by Guerbet.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 315 participants
- Enrollment target
Study Summary
Compare the diagnostic performance of gadopiclenol against gadoterate meglumine in patients with vascular diseases of supra-aortic, peripheral, or abdominal / renal arteries using MRI
Interventions
- DRUG gadopiclenol
- DRUG Gadoterate meglumine (Dotarem)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2026-02-02 |
| Est. Completion | 2027-12-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07348640
The ClinicalTrials.gov registry entry for NCT07348640 describes a study currently listed as not yet recruiting, categorized as Phase 3. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Guerbet, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which gadopiclenol is the first listed.
NCT07348640 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07348640 about?
NCT07348640 is a clinical study titled "Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease". Compare the diagnostic performance of gadopiclenol against gadoterate meglumine in patients with vascular diseases of supra-aortic, peripheral, or abdominal / renal arteries using MRI
What is the current status of trial NCT07348640?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 315 participants. The study started on 2026-02-02. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07348640?
The interventions under investigation include: gadopiclenol (DRUG), Gadoterate meglumine (Dotarem) (DRUG).
Who is sponsoring clinical trial NCT07348640?
This trial is sponsored by Guerbet, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.